Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Akdis

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Allergy|November 19, 2017
Allergen manufacturing and quality aspects for allergen immunotherapy in Europe and the United States: An analysis from the EAACI AIT Guidelines ProjectA Bonertz, G Roberts, J E Slater, et al.
Allergy|August 4, 2017
Challenges in the implementation of EAACI guidelines on allergen immunotherapy: A global perspective on the regulation of allergen productsA Bonertz, G C Roberts, M Hoefnagel, et al.
Allergy|February 2, 2026
The Unmet Need of Olfactory Testing in Inflammatory Disorders of the Upper Airways-An EAACI Position PaperL Klimek, J Mullol, Th Hummel, et al.
Allergy|July 22, 2014
Global Allergy Forum and Second Davos Declaration 2013 Allergy: Barriers to cure--challenges and actions to be takenJ Ring, C Akdis, R Lauener, et al.
Allergy|January 13, 2012
Davos declaration: allergy as a global problemJ Ring, C Akdis, H Behrendt, et al.
Allergy|March 30, 2016
Global Allergy Forum and 3rd Davos Declaration 2015: Atopic dermatitis/Eczema: challenges and opportunities toward precision medicineT Bieber, C Akdis, R Lauener, et al.
Laryngo- Rhino- Otologie|August 22, 2020
[Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI-AeDA-GPA-DGAKI Position Paper (Pocket-Guide)]O Pfaar, L Klimek, M Worm, et al.
Allergy|April 28, 2015
Are allergic multimorbidities and IgE polysensitization associated with the persistence or re-occurrence of foetal type 2 signalling? The MeDALL hypothesisJ Bousquet, J M Anto, M Wickman, et al.
Allergy|March 13, 2016
Paving the way of systems biology and precision medicine in allergic diseases: the MeDALL success story: Mechanisms of the Development of ALLergy; EU FP7-CP-IP; Project No: 261357; 2010-2015J Bousquet, J M Anto, M Akdis, et al.
The Journal of Nutrition, Health & Aging|December 22, 2016
Building Bridges for Innovation in Ageing: Synergies between Action Groups of the EIP on AHAJ Bousquet, M Bewick, A Cano, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Allergy|November 19, 2017
Allergen manufacturing and quality aspects for allergen immunotherapy in Europe and the United States: An analysis from the EAACI AIT Guidelines ProjectA Bonertz, G Roberts, J E Slater, et al.
Allergy|August 4, 2017
Challenges in the implementation of EAACI guidelines on allergen immunotherapy: A global perspective on the regulation of allergen productsA Bonertz, G C Roberts, M Hoefnagel, et al.
Allergy|February 2, 2026
The Unmet Need of Olfactory Testing in Inflammatory Disorders of the Upper Airways-An EAACI Position PaperL Klimek, J Mullol, Th Hummel, et al.
Allergy|July 22, 2014
Global Allergy Forum and Second Davos Declaration 2013 Allergy: Barriers to cure--challenges and actions to be takenJ Ring, C Akdis, R Lauener, et al.
Allergy|January 13, 2012
Davos declaration: allergy as a global problemJ Ring, C Akdis, H Behrendt, et al.
Allergy|March 30, 2016
Global Allergy Forum and 3rd Davos Declaration 2015: Atopic dermatitis/Eczema: challenges and opportunities toward precision medicineT Bieber, C Akdis, R Lauener, et al.
Laryngo- Rhino- Otologie|August 22, 2020
[Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI-AeDA-GPA-DGAKI Position Paper (Pocket-Guide)]O Pfaar, L Klimek, M Worm, et al.
Allergy|April 28, 2015
Are allergic multimorbidities and IgE polysensitization associated with the persistence or re-occurrence of foetal type 2 signalling? The MeDALL hypothesisJ Bousquet, J M Anto, M Wickman, et al.
Allergy|March 13, 2016
Paving the way of systems biology and precision medicine in allergic diseases: the MeDALL success story: Mechanisms of the Development of ALLergy; EU FP7-CP-IP; Project No: 261357; 2010-2015J Bousquet, J M Anto, M Akdis, et al.
The Journal of Nutrition, Health & Aging|December 22, 2016
Building Bridges for Innovation in Ageing: Synergies between Action Groups of the EIP on AHAJ Bousquet, M Bewick, A Cano, et al.
Pageof 3